In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Abbott licenses sertindole (antipsychotic) from Lundbeck

Executive Summary

Abbott has licensed exclusive US development, manufacturing and marketing rights to sertindole, an antipsychotic for the treatment of schizophrenia, from H. Lundbeck A/S, a Danish pharmaceutical company specializing in central nervous system drugs.
Deal Industry
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • R+D and Marketing-Licensing

Related Companies

UsernamePublicRestriction

Register